Clinical Trial Update: Methotrexate - Inadequate Response Device Sub-Study [Phase 3]

View source ↗

Summary

Phase 3 sub-study evaluating a device for rheumatoid arthritis patients with inadequate response to methotrexate has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis (RA) | Phase 3 | Status: COMPLETED | Results posted: 2011-07-06